Objective: Previous studies have suggested that glycogen expression in the vaginal epithelium decreases during menopause, resulting in reduced levels of lactobacilli. However, free glycogen in genital fluids and its relationship with Lactobacillus levels have not been compared in premenopausal and postmenopausal women.
T he lower genital tract of many reproductive-age women is colonized predominantly by Lactobacillus species. Lactobacillus inhibits the development of bacterial vaginosis (BV) and significantly lowers the risk of acquiring several sexually transmitted infections, including HIV, HSV-2, Neisseria gonorrhoeae, and Chlamydia trachomatis. 1, 2 In HIV-infected women, those with higher genital levels of lactobacilli shed less viruses in their vaginal fluids and are less likely to transmit HIV to their partner. 3, 4 Colonization with lactobacilli is also associated with a lower risk of pelvic inflammatory disease and pregnancy-related complications, including preterm labor. 1, 2 In postmenopausal women, a decrease in Lactobacillus relative abundance is associated with signs of vulvovaginal atrophy 5 and increased risk of urinary tract and sexually transmitted infections. 6, 7 Lactobacillus therefore plays an important beneficial role in the health of both premenopausal and postmenopausal women.
It has long been recognized that vaginal Lactobacillus levels, estrogen, and vaginal glycogen vary during different stages of life. 8<10 Around the onset of puberty, the female lower genital tract typically becomes colonized with Lactobacillus species, and vaginal pH decreases. These changes are concurrent with an increase in circulating estrogen and are accompanied by a rise in glycogen deposits in vaginal epithelial cells. 8 During menopause, epithelial glycogen in the vagina is reportedly reduced, 11 and the relative abundance of Lactobacillus is decreased. 5 These observations have led to the hypothesis that, during menopause, a reduction in estrogen leads to reduced glycogen deposition in the vaginal epithelium, which in turn negatively impacts vaginal Lactobacillus levels.
However, several studies did not find a clear relationship among menopause, estrogen, glycogen, and Lactobacillus. For example, significant glycogen staining was observed in epithelial cells from vaginal smears of postmenopausal women and ovariectomized women. 12, 13 Furthermore, intraepithelial glycogen content was reported to be independent of hormonal changes. 14 Moreover, Lactobacillus species dominated the vaginal microbiota in postmenopausal womenValbeit to a lesser extent than what was found in premenopausal women. 5 Recent studies have suggested that the amount of free glycogen in genital fluids may be more closely associated with Lactobacillus levels in the genital tract than other measures such as epithelial glycogen. 15<17 Free glycogen is defined as soluble glycogen in genital fluids that is not cell-associated. However, most studies of vaginal glycogen have not measured the concentration of free glycogen in genital fluids and have not established how menopause would affect free glycogen levels. Therefore, in this exploratory study, we investigated the hypothesis that women in menopause would have lower levels of free glycogen and Lactobacillus in their genital fluids than premenopausal women. Because some species of Lactobacillus (ie, Lactobacillus crispatus and Lactobacillus jensenii) are thought to be more protective than others (ie, Lactobacillus iners), 18<21 we also compared the levels of these three species in premenopausal and postmenopausal women.
METHODS

Ethics statement
The Institutional Review Boards of Rush University Medical Center and Cook County Health and Hospitals System approved the study, and a written informed consent form was obtained from all participants.
Participants and sample acquisition
Vaginal fluid samples were collected from participants in a longitudinal study designed to investigate the effects of sex hormones on A-catenin signaling and HIV infection (manuscript in preparation). Samples were collected from 11 premenopausal (4 HIV-negative and 7 HIV-positive) and 12 postmenopausal (7 HIV-negative and 5 HIV-positive) participants. Samples were collected at the Ruth M. Rothstein CORE Center, Cook County Health and Hospitals System (Chicago, IL). Premenopausal women had self-reported regular menstrual cycles of between 25 and 30 days for 6 months before study entry. Postmenopausal women referred to women who have had more than 12 months of amenorrhea. HIV infection was confirmed by enzyme-linked immunosorbent assay and Western blot analysis. HIV-infected women had stopped antiretroviral therapy for at least 6 months before enrollment in this study. All women had not taken birth control pills for at least 2 months before study entry and were asked to abstain from vaginal intercourse, vaginal spermicides, douches, or other vaginal topical agents for 48 hours before sample collection. Presence of Trichomonas vaginalis was determined by wet mount. BV was determined by Amsel criteria 22 ; samples were collected from women with active BV or other sexually transmitted infections diagnosed during a visit. Women were treated and asked to return during the next menstrual cycle. Those with irregular menstrual cycles and those taking hormone-based birth control were deemed ineligible.
Cervicovaginal lavage (CVL) samples were obtained by irrigation of the cervix with 10 mL of nonbacteriostatic sterile saline, followed by aspiration from the posterior fornix. Premenopausal women were asked to come to the clinic 2 to 5 days after the start of menses and on the following days to represent distinct stages of the menstrual cycle: days 7 to 13 (follicular phase), days 14 to 20 (early luteal phase), and more than 21 days (late luteal phase). Premenopausal women were followed for approximately two menstrual cycles. Postmenopausal women were sampled at two visits, approximately 1 month apart. At each visit, blood was drawn to measure serum levels of progesterone and estradiol (Quest Diagnostics, Madison, NJ). All samples collected from an individual were assayed together as a batch. Estrogen cutoffs were selected by dividing all samples (premenopausal and postmenopausal) into tertiles. pH of vaginal secretions was determined before CVL collection by adding genital fluids to indicator strips with a pH range of 4 to 7 (ColorpHast indicator strips; MCB Reagents, Gibbstown, NJ).
Polymerase chain reaction quantification of bacteria
Bacteria in CVL samples were pelleted by centrifugation at 13,200 rpm for 25 minutes. Cell-free supernatant was used to quantify free glycogen (see later discussion). DNA was isolated from pellet with a FastDNA SPIN kit according to the manufacturer's instructions (MP Biomedicals, Solon, OH). The final elution volume was 100 KL. DNA concentration was determined by a NanoDrop 2000 spectrophotometer.
Bacteria-specific quantitative polymerase chain reaction (qPCR) assays were performed on isolated CVL genomic DNA. Each 20 KL of qPCR contained 1Â iTaq Universal Probes Supermix 172-5134 (Bio-Rad, Hercules, CA), 1Â PrimeTime Standard qPCR Assay (IDT, Coralville, IA) primers/probes mixture, and 1 to 25 ng of template DNA. PCR conditions included the following: premelt at 95-C for 3 minutes, 50 cycles of 95-C for 30 seconds (melt), 55-C to 65-C for 30 to 60 seconds (annealing), and 65-C to 72-C for 30 to 60 seconds (extension). Primers and probes for the bacteria had been described previously. 23, 24 Known quantities of 16S ribosomal RNA plasmid targets were used as standard. 23, 24 Real-time PCR was carried out on an Applied Biosystems 7900HT Fast Real-Time PCR System. The final quantity of Lactobacillus was calculated by adding the numbers of 16S ribosomal RNA copies per 1-mL CVL of L. crispatus, L. iners, and L. jensenii.
Glycogen measurement
Free glycogen in cell-free genital fluids was measured fluorometrically (Glycogen Assay Kit; BioVision, Milpitas, CA). Briefly, 10 KL of genital fluids or saline (serving as blank) was added to test wells in a 96-well plate. The volume was adjusted to 50 KL with hydrolysis buffer, with or without the kit hydrolysis enzyme. Glucose background (samples without hydrolysis enzyme) was subtracted to determine glycogen concentration. Relative fluorescence units were measured using a BioTek Synergy HT plate reader (BioTek Instruments Inc, Winooski, VT).
Statistical analysis
Descriptive statistical analyses were performed using the Instat statistical software package (GraphPad Software). Nonparametric methods were used for comparisons and correlations, as indicated in figure legends. P e 0.05 indicated statistical significance.
Models accounting for repeated measures were considered. Because of the small sample size and because there were only two measurements available for postmenopausal women, more sophisticated repeated-measures statistical models did not fit. Instead, the models considered were run on a subset of the study sample. Specifically, the modeling portion of the analysis focused on premenopausal women with one complete menstrual cycle. The subset of the sample includes seven HIV-infected premenopausal women and four HIV-uninfected premenopausal women, each with three repeated measurements (taken at the follicular, luteal, and late luteal phases of one cycle) for variables of interest.
Numerical summaries (medians and interquartile ranges) of key variables of interest were explored by HIV status and cycle phase. The statistical significance of the effect of HIV status and phase on each variable was tested separately using repeated-measures analysis of variance. Separate mixedeffects models were fitted for the subset of samples (described above) to explore the relationships of Lactobacillus with estrogen, progesterone, glycogen, and pH. Each model was also adjusted for HIV status and menstrual cycle phase. Repeated measures were accounted for by using an unstructured covariance matrix. Akaike information criterion, Bayesian information criterion, and likelihood ratio test were carried out to assess model fit and the appropriate structure of the variancecovariance matrix. The unstructured covariance matrix provided a statistically superior fit compared with all other structures for these data. Mixed-models diagnostics included an assessment of predicted profiles for each participant. The chosen models provided an adequate statistical fit to the data. All statistical analyses were fitted using the PROC MEANS, PROC GLM, and PROC MIXED procedures in SAS version 9 (SAS Institute, Cary, NC).
RESULTS
Glycogen levels in genital fluids of premenopausal and postmenopausal women
Eighty-two CVL samples were collected from 23 women. Participant characteristics are summarized in Table 1 . Ninetyone percent of women were African American; 4% of the women were positive for T. vaginalis at the time of collection, 2% were positive for Candida albicans, and 11% were positive for BV (Amsel criteria). None of the HIV-infected women were taking antiretroviral therapy at the time of sampling.
The amount of free glycogen in the 82 vaginal fluid samples was measured and showed a wide distribution ranging from 0 to 0.487 Kg/KL (coefficient of variation, 130.7%; Fig. 1A ). Samples from postmenopausal women had significantly lower levels of free glycogen compared with those from premenopausal women (median, 0.002 vs 0.065 Kg/KL, respectively; P = 0.03).
When examined at the individual level, some premenopausal women had consistently low levels of free glycogen (eg, individuals 3 and 23; Fig. 1B ), whereas others exhibited higher levels of free glycogen (individual 14; Fig. 1B ). When all time points were analyzed, individual 23 had significantly lower glycogen levels than individuals 11 and 14 (P G 0.01). Interestingly, free glycogen levels in most of the premenopausal women fluctuated considerably during the study period ( Fig. 1B) .
Five postmenopausal women had consistently low levels of free glycogen (participants 2, 9, 12, 16, and 24; Fig. 1C ), whereas three had substantial levels of glycogen compared with premenopausal women (participants 5, 7, and 19; Fig. 1C ). There was no significant association between age and glycogen levels in either premenopausal or postmenopausal women (data not shown).
Lactobacillus levels correlate positively with free glycogen in premenopausal and postmenopausal women Because lactobacilli in the lower genital tract have been postulated to use glycogen as energy source, 8, 25 we examined the relationship between total Lactobacillus levels and free glycogen in vaginal fluids. Lactobacillus and glycogen correlated strongly in both premenopausal (Spearman r = 0.68, P G 0.0001; Fig. 2 ) and postmenopausal (Spearman r = 0.60, P G 0.002) women. Of the three vaginal Lactobacillus species measured (L. iners, L. crispatus, and L. jensenii), there was a positive correlation between L. iners and glycogen levels in all samples ( Fig. 1 , Supplemental Digital Content 1, http://links.lww.com/MENO/A123) and in either premenopausal (Spearman r = 0.6, P G 0.0001) or postmenopausal (r = 0.7, P G 0.0001) samples. Likewise, L. jensenii levels were significantly associated with free glycogen in all samples (Fig. 1 , Supplemental Digital Content 1, http://links.lww.com/MENO/A123) and in either premenopausal (r = 0.4, P G 0.0006) or postmenopausal (r = 0.65, P G 0.0006) samples. However, there was no significant association between L. crispatus and gly-cogen in either group (Fig. 1 , Supplemental Digital Content 1, http://links.lww.com/MENO/A123; data not shown).
We also compared the levels of L. iners, L. crispatus, and L. jensenii in samples from premenopausal women with those from postmenopausal women. There was a trend toward higher L. iners levels in premenopausal samples (P = 0.11; Table 2 ). L. crispatus and L. jensenii levels were not significantly different ( Table 2) .
There was a trend toward lower vaginal pH in samples from premenopausal women (median, 4.0) compared with samples from postmenopausal women (median, 4.6; P = 0.09; Table 2 ). As expected, estrogen levels were significantly higher in premenopausal women than in postmenopausal women (median, 122 vs 24.5 pg/mL; coefficient of variation, 70.6%; P G 0.0001). Likewise, progesterone levels were significantly higher in premenopausal women (median, 0.5 vs 0 ng/mL; coefficient of variation, 289%; P = 0.002; Table 2 ).
Overall, Lactobacillus levels in premenopausal and postmenopausal HIV-positive samples did not differ significantly (data not shown). Of the Lactobacillus species examined, no significant differences were observed between premenopausal and postmenopausal HIV-positive samples (data not shown). In unadjusted repeated-measures analysis of variance, HIV status was not significantly associated with pH, glycogen, or Lactobacillus levels.
Our attempts to assess the relationship between glycogen and Lactobacillus in premenopausal and postmenopausal women, although taking into account repeated measures, were unsuccessful because there were only two measurements available for each of the postmenopausal women. In fitting our mixed-effects models, we therefore restricted our analyses to premenopausal women and found that there was a statistically significant positive relationship between glycogen and Lactobacillus after adjusting for HIV status and menstrual cycle phase (A = 6.89, P = 0.02). Likewise, there was a statistically significant negative relationship between pH and Lactobacillus after adjusting for HIV status and menstrual cycle phase (A = j2.85, P G 0.001).
Relationship of estrogen with glycogen and Lactobacillus
Estrogen has been postulated to influence glycogen expression by vaginal epithelial cells, 11 although its effect on free glycogen has not been determined. We therefore investigated the relationship between estrogen and glycogen by dividing the premenopausal samples into three groups; high estrogen (9134 pg/mL), intermediate estrogen (67-133 pg/mL), and low estrogen (G67 pg/mL; Table 3 ). Glycogen was not significantly different in the three groups (median, 0.053 vs 0.063 vs 0.14 Kg/KL, respectively; P = 0.9). There were also no significant differences in vaginal pH, total Lactobacillus levels, or levels of different Lactobacillus species in the three groups. Similarly, no significant differences in glycogen or Lactobacillus levels were observed when all samples (regardless of menopause status) were compared by estrogen level (Kruskal-Wallis test, P 9 0.05; Table 1 , Supplemental Digital Content 2, http://links.lww.com/MENO/A124).
We also assessed the effects of the different phases of the menstrual cycle on glycogen and Lactobacillus levels in premenopausal women, taking into account repeated measures (see previous discussion). Our analyses showed that glycogen and total Lactobacillus levels did not significantly vary at different stages of the menstrual cycle (data not shown).
DISCUSSION
In this study, we quantified the levels of free glycogen and Lactobacillus in vaginal fluids obtained from premenopausal and postmenopausal women. Although glycogen in the epithelium or in epithelial cells has been measured in previous studies, the concentration of free glycogen in genital fluid samples, to our knowledge, has not been quantified and compared with the levels of Lactobacillus in either premenopausal or postmenopausal women. We posit that the amount of free glycogen is a biologically important measurement because it represents the amount of glycogen that is available for utilization by Lactobacillus in the vaginal lumen.
A major finding of this study is that there was a strong positive correlation between free glycogen and Lactobacillus levels in samples from both premenopausal and postmenopausal women (Fig. 2) . This is an important finding because it provides additional evidence for the proposed role of glycogen in supporting the in vivo growth of genital Lactobacillus. This finding also supports the proposition that measurement of free glycogen is a biologically meaningful parameter. However, further studies are needed to more definitively establish any relationship between glycogen levels and Lactobacillus colonization in the female genital tract.
The observed strong correlation between glycogen and Lactobacillus in postmenopausal women was somewhat surprising because estrogen levels were relatively low in postmenopausal women and glycogen expression by vaginal epithelial cells was thought to be influenced by changes in estrogen levels. 11 Thus, our studies indicate that some postmenopausal women can have substantial amounts of glycogen and Lactobacillus despite low estrogen levels. A recent study found that Lactobacillus dominated the vaginal microbiota of most postmenopausal women, although to a lesser extent than what was found in premenopausal women. 5 Another study showed that glycogen could still be detected in vaginal smears obtained from postmenopausal women. 13 It is possible that other hormones, such as estrone (the predominant form of estrogen in postmenopausal women 26 ), could affect free glycogen levels.
The lack of a significant association between estrogen and glycogen in premenopausal women was unexpected and could be attributable to the relatively small sample size of this study. These results could also be explained by the timing of sample collection, such that a rapid rise (or fall) in estrogen levels 27 could have been missed. It is also possible that glycogen release into the lumen may be delayedVby as many as several daysVafter a change in circulating estrogen and/or an increase in intraepithelial glycogen levels. However, Gregoire et al 14 found that menstrual cycle stage in premenopausal women had no significant relationship with glycogen levels in hydrolyzed vaginal biopsies. Interestingly, we found that free glycogen levels changed substantially across relatively short periods in both premenopausal and postmenopausal women. Large changes were observed in some premenopausal women even when visits were only 1 week apart. Given the strong correlation between glycogen and Lactobacillus, periods of low glycogen availability in the vaginal lumen might render a woman vulnerable to vaginal infections and other risks associated with low Lactobacillus levels. A recent study by Gajer et al 28 assessed the genital microbiota in healthy women several times per week and found that the genital microbiota changed substantially in many of the women during the course of a few days. For example, participant 24 in that study had microbiota consisting of more than 70% L. crispatus on week 4. By the middle of that week, the microbiota was less than 10% L. crispatus; however, by the end of that week, it had returned to more than 60% L. crispatus. Similar rapid changes were observed in this participant on weeks 8 and 12 of the 15-week study period. Such rapid changes in microbiota were observed in most of the women in that study. Although glycogen levels were not assessed in that study, sudden changes in free glycogen could have contributed to the marked variation observed in microbiota. However, it is also possible that changes in the relative abundance of other microbes (eg, Gardnerella), however transient, could be responsible for changes in the relative abundance of Lactobacillus species.
It will be important to study factors associated with an increase in free glycogen concentrations. In a recent study, 17 we observed that having a recent sexual partner (vs no partner) was negatively associated with free glycogen, whereas body mass index was positively associated. Further studies are needed to determine whether glycogen is indeed increased in the vaginal epithelium or whether it is instead released into the vaginal lumen at a higher rate. Thus, a critical question is whether glycogen levels in vaginal fluids are associated with changes in glycogen deposits in the vaginal epithelium.
CONCLUSIONS
Taken together, our data show that glycogen levels are significantly associated with Lactobacillus levels in both premenopausal and postmenopausal women. This finding suggests that persistently low levels of free glycogen in both premenopausal and postmenopausal women might increase the risk of adverse effects associated with low Lactobacillus levels. Furthermore, these studies point to the need to further investigate biological factors that affect free glycogen levels and further suggest that designing interventions that increase free glycogen levels and maintain them could positively impact women's health.
